Kazuki Fujii^1,2,3, Koshidaka Yumie², Mayumi Adachi², Yuko Yanagibashi², Mina matsuo², Shoko Hongo², Hirofumi Nishizono⁴, Ichiro Takasaki⁵, Nobuyuki Kurosawa^5,7, Yasunori Aizawa⁶, *Keizo Takao^1,2,3,7 (1. Department of Behavioral Physiology, Faculty of Medicine, University of Toyama, 2. Life Science Research Center, University of Toyama, 3. Research Center for Idling Brain Science, University of Toyama, 4. Kanazawa Medical University Medical Research Institute, 5. Faculty of Engineering, University of Toyama, 6. School of Life Science and Technology, Tokyo Institute of Technology, 7. Center for Advanced Antibody Drug Development, University of Toyama,)

*Takahiro Seki^1,2, Tomoko Ohta², Yuri Morikawa², Ayumu Konno³, Hirokazu Hirai³, Yuki Kurauchi², Hiroshi Katsuki² (1. Dept Pharmacol, Fac Pharm Sci, Himeji Dokkyo Univ, 2. Dept Chemico-Pharmacol Sci, Grad Sch Pharm Sci, Kumamoto Univ, 3. Dept Neurophysiol Neural Rep, Gunma Univ Grad Sch Med)

*Kurumi Goto¹, Miku Hirata¹, Mei Onishi¹, Kensuke Yamashita¹, Minoru Narita^1,2, Tomohisa Mori¹ (1. Dept. Pharmacol., Hoshi Univ., Tokyo, Japan, 2. Div. Pathophysiol., Natl. Cancer Ctr. Res. Inst., Tokyo, Japan)

*Takashi Iwai¹, Hayato Ohsumi¹, Momoka Koyama¹, Moka Yoshida¹, Ayano Nagase¹, Misa Oyama¹, Shun Watanabe¹, Mitsuo Tanabe¹ (1. Laboratory of Pharmacology, school of Pharmacy, Kitasato university)

*Masahiro Ohsawa¹, Kousuke Tatsuta⁴, Austin Ganaway³, Ryoma Okada², Yoshinori Sunaga², Yasumi Ohta², Yasemin Akay³, Metin Akay³, Jun Ohta² (1. Faculty of Pharma-Sciences, Teikyo University, 2. Nara Institute of Science and Technology, 3. Cullen College of Engineering, University of Houston, 4. Faculty of Pharmaceutical Sciences, Nagoya City University)

*Zhiqian Yu¹, Mai Sakai², Yoshie Kikuchi¹, Chiaki Ono¹, Mizuki Hino³, Yasuto Kunii³, Hiroaki Tomita¹ (1. Department of Psychiatry, Graduate School of Medicine, Tohoku University, 2. Department of Psychiatric Nursing, Graduate School of Health Science, Tohoku University, 3. Department of Disaster Psychiatry, International Research Institute of Disaster Science (IRIDeS), Tohoku University)

*Megumi Furukawa^1,2, Takayuki Kobayashi³, Ryoken Aoki², Takayuki Manabe⁴, Hideo Matsuzaki¹, Nobuo Izumo³ (1. Dept of Functional Brain Activities, United Grad Sch of Child Dev, 2. Center for Pharmaceutical Education, Yokohama Univ of Pharmacy, 3. Lab of Pharmacotherapy, Yokohama Univ of Pharmacy, 4. Chukyogakuin Univ)